Savara, Inc. (SVRA)
4.96
-0.20
(-3.88%)
USD |
NASDAQ |
Mar 20, 16:00
4.98
+0.02
(+0.40%)
After-Hours: 20:00
Savara EPS Diluted (Quarterly) : -0.1341 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.6903 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.24M |
| Total Expenses (Quarterly) | 32.24M |
| Enterprise Value | 809.31M |
| Earnings Yield | -10.77% |
| Normalized Earnings Yield | -10.74 |